Medtronic Inc see 15 pct growth sale earnings end April 30 1988. At analyst meeting company end April 30 1987 earn 73 mln dlrs 5.15-5.35 dlrs share sale 500 mln dlrs. In ago period company earn 53.4 mln dlrs 3.65 dlrs share sale 402.8 mln dlrs. Winston Wallin Medtronic chairman company improve market share fiscal 1988 cardiac pacemaker expand cardiovascular therapeutic product line. Wallin caution analyst quickly change share estimate company Medtronic heavy sale marketing expense fiscal 1988. He company intend reinvest earnings business dividends. "Shareholders grow reinvest dividend share repurchases" said. Wallin see Medtronic's share total worldwide pacemaker market increase 42 pct fiscal 1988 40 pct fiscal 1987. He worldwide market cardiovascualr therapeutic product include pacemaker valve catheter laser value 2.5 billion dlrs 1990 double 1995. Wallin "Our objective hold product start building market share beg borrow steal markets." In past Medtronic's pacemaker plague problem lead product recalls. Regulators criticize industry cite quality problem needle overprescription pacemakers. "We knowledge major problem pacemaker leads" Wallin said. "We intend re-establish company quality leader industry." Glen Nelson executive vice president Medtronics company intend diversify internally acquisition company area Medtronic's expertise drug delivery systems. Wallin 15 pct earnings growth fiscal 1988 include dilution acquisitions. "We hope safety provision won't major dilution acquisition." Wallin company virtual exclusivity rate responsive pacemaker fiscal 1988. The company market Activitrax single chamber pacemaker varies heartrate response physical activity. Siemens AG West German company develop rate responsive pacemaker. Reuter 